December 18, 2006
Dr. Terri Stewart, Lead, Environmental Biomarkers Initiative, Pacific Northwest National Laboratory, 6-7-06
The Environmental Biomarkers Initiative at Pacific Northwest National Laboratory is designed to lead the transformation of environmental management from a descriptive to a predictive science. Dr. Terri Stewart is responsible for implementing the Initiative’s research agenda: predicting ecosystem change and damage, answering questions around engineered nanomaterials and their impact on human and ecosystem health, and developing rapid and pre-symptomatic screening methods for zoonotic agents.
Previously, Dr. Stewart was Vice President of Battelle’s Core Technology Organization, where she led the integrated business and technology development strategy for nano- and microtechnologies. She received the R&D 100 Award in 1991 for the Waste Acid Detoxification and Reclamation technology.
Dr. Kristen Kulinowski, Director, International Council on Nanotechnology, and Executive Director for Education and Public Policy, Center for Biological and Environmental Nanotechnology, Rice University, 5-3-06
The Center for Biological and Environmental Nanotechnology at Rice University aims to shape nanoscience into a discipline with the relevance, triumphs, and vitality of a modern-day polymer science. Dr. Kristen Kulinowshi has studied how material structured on the nanometer length scale can be used to manipulate light through the creation of a "photonic band gap". She worked in the D.C. office of a member of the U.S. House of Representatives on issues such as weapons of mass destruction, antiterrorism legislation, and domestic nuclear power security.
Dr. Michael Bockstaller, Assistant Professor, Materials Science and Engineering, Carnegie Mellon University, 5-3-06
Dr. Michael Bockstaller’s research interests include polymer-based nanostructures and nanoparticle assemblies; field-responsive nanoparticles for drug delivery; X-ray and neutron scattering; and electron microscopy. He is a fellow of the Alexander von Humboldt foundation and Emmy Noether grant recipient of the German Science Foundation.
Dr. Anand Gadre, Assistant Professor, College of Nanoscale Science and Engineering, University of Albany–SUNY, 4-19-06
At the College of Nanoscale Science and Engineering, Dr. Anand Gadre’s research centers around micro-electro-mechanical Systems, including novel process integration techniques for polymeric BioMEMS and bionanotechnology. His research interests also focus on biomedical applications such as development of noninvasive nanoscale sensors and drug delivery systems and cell transfection microdevices. Dr. Gadre’s group also focuses on conducting polymers, in particular the synthesis of conducting/insulating polymeric composite films and nanofibers,and the application of these polymeric composites as chemical and biological sensors, polymeric LED, and polymeric rechargeable batteries.
Dr. Scott Huxtable, Assistant Professor, Department of Mechanical Engineering, Virginia Tech, 4-12-06
Dr. Scott Huxtable leads the Nanoscale Energy Transport Laboratory where he and his students examine a variety of topics related to the flow of energy at the molecular level. They are interested in understanding the fundamental physics that control nanoscale energy transport as well as developing devices that are based on the underlying physics. Dr. Huxtable and his team are developing a variety of thermoelectric systems including coolers, power generators, and heat flux sensors.
In January 2006, Dr. Huxtable was awarded a National Science Foundation Faculty Early Career Development Program (CAREER) Award, which is the National Science Foundation's most prestigious award for creative junior faculty. This five-year grant will support some of Dr. Huxtable’s nanoscale thermal transport studies, the creation of a new “Nanoengineering” class at Virginia Tech, and a summer program to introduce engineering to underrepresented minority high school students.
December 14, 2006
Dr. Howard Perko, CTL|Thompson Northern Colorado Division Manager, 12-15-06
Dr. Howard Perko has more than 12 years of professional experience and holds B.S., M.S., and Ph.D. degrees in Civil Engineering with Geotechnical/Foundation Engineering specialization. He is a licensed professional engineer in 12 states and his project experience includes earth dams, slope stability, excavation shoring, earth retention, underpinning, dewatering systems and foundations. Dr. Perko is an active member of the American Society of Civil Engineers and Deep Foundations Institute among other organizations and has authored more than 25 technical publications on topics including earth anchors, helix piers, soil shear strength, underground corrosion, deep foundations and expansive soils.
Dr. Perko was employed as a Project Engineer with CTL|Thompson from 1994 to 1998 before enrolling in the doctoral program at Colorado State University. As part of his graduate and postgraduate work, he assisted the NASA Jet Propulsion Laboratory as a planetary soil scientist on the design of soil anchors, dust mitigation systems, soil and ice drills, and soil sampling devices. He subsequently started several companies including SECURE Foundations, LLC and SECURE Engineering Denver, LLC, which focus on structural engineering with particular emphasis in foundations and retaining walls.
In 2005, CTL|Thompson and the two SECURE companies joined forces to create a stronger and more diversified team. Dr. Perko re-joined the CTL|Thompson team in 2005 as the Northern Colorado Division Manager. In Dr. Perko’s current role, his duties include managing the Fort Collins CTL|Thompson office and the SECURE companies, developing new clients, serving existing clients, reviewing reports, directing engineering investigations, and supervising engineering designs.
Dr. Richard Stock, Professor and Chair of Radiation Oncology, Barbara and Maurice A. Dean Prostate Health and Research Center, Mount Sinai School of Medicine and Mount Sinai Hospital, 12-15-06
Dr. Richard Stock is Professor and Chair of Radiation Oncology at the Barbara and Maurice A. Dean Prostate Health and Research Center at Mount Sinai School of Medicine and Mount Sinai Hospital. Dr. Stock is a pioneer in the development of state-of-the-art approaches for radioactive seed implantation in the treatment of prostate cancer. He leads the development of this area as an integral component of the Center's activity in the treatment of localized, locally advanced, and recurrent prostate cancer. He also coordinates combination approaches using radiation treatment and orchestrates research programs in this area.
The Barbara and Maurice A. Deane Prostate Health and Research Center at Mount Sinai School of Medicine/Mount Sinai Hospital represents a new and unique concept in men's health. The Center brings together multiple disciplines and their support services to provide state-of-the-art assessment and care in a comprehensive and coordinated manner for all conditions involving the prostate. Important to this mission is the provision of the necessary infrastructure to support clinical investigations of new ideas and to broaden further opportunities for advancement in our understanding of the various conditions.
Within this collaborative atmosphere, the program acts as a catalyst for translational activities (i.e., basic scientific research with direct clinical application) by investigators at the Mount Sinai School of Medicine to further interest and enhance opportunities for new avenues in diagnosis and treatment. In bringing together multiple clinical disciplines to provide state-of-the-art assessment and care in a fully supported investigative atmosphere, the Center provides immediate access to information and expertise empowering individuals and their families to choose their own path of care.
Dr. William Johnson, Vice Chairman of the Board for Technology, Liquidmetal Technologies, and Ruben and Donna Mettler Professor of Material Science, California Institute of Technology, 12-15-06
Dr. William Johnson is Vice Chairman of the Board for Technology for Liquidmetal Technologies. He directed the research that led to the discovery of Liquidmetal alloy.
In addition to serving on the Liquidmetal Technologies Board, Dr. Johnson is the Ruben and Donna Mettler Professor of Material Science at Caltech. He received his BA in Physics from Hamilton College and his PhD in Applied Physics from Caltech. He spent two years at IBM's Research Center (1975-1977).
Dr. Johnson held a Visiting Professor appointment at the Metal Physics Institute in Gottinghen, Germany (1983) and received a Von Humbolt Distinguished Scientist Fellowship in Gottingen (1988). He is the 1995 recipient of the TMS/AIME Hume Rothery Award for his experimental work. o
Liquidmetal Technologies, a publicly traded company (OTC:LQMT), is a leading force in the research, development and commercialization of amorphous metals. The Company’s revolutionary class of patented Liquidmetal alloys and coatings form the basis of high performance materials that are utilized in a range of military, consumer and industrial products.
Liquidmetal alloys were discovered by researchers at California Institute of Technology and are characterized as amorphous alloys that are two to three times stronger than commonly used titanium alloys, retain the malleability of plastic, and are relatively non-corrosive and wear-resistant. Not only do Liquidmetal alloys provide applications that were not possible before, but they also present new opportunities for the current and future designs of metallic based products. This revolutionary class of patented alloys and coatings may change the performance and cost paradigms for materials science.
Liquidmetal Technologies principal executive offices and Corporate Technology Center are located in Lake Forest, CA.
December 07, 2006
Tim Taylor, Mission Operations Controller, Southern Research Institute, and Dr. Martin Ross, Program Manager, NASA WB-57F Ascent Video Experiment (WAVE) project, Aerospace Corporation, 12-8-06
Prior to joining Southern Research Institute, Tim Taylor was a consultant for a number of technology interests including NASA, British Aerospace, and the Department of Defense. He was previously a venture capitalist for HMC Corporation, a division of Harbert Management Corporation. Earlier in his career, he worked with the NASA space program at Cape Canaveral–Kennedy Space Center and the Marshall Space Flight Center, where his primary functions were to help transition from the Apollo program to the space shuttle program, and provide pre-flight and in-flight engineering and technical support for several space shuttle missions/payloads. He has been involved in the development of many products and processes ranging from material science, coatings and surgical devices, and holds 14 patents himself.
Dr. Martin N. Ross is currently the Program Manager for the NASA WB-57F Ascent Video Experiment (WAVE) project at the Aerospace Corporation. Dr. Ross has over 30 years experience in aerospace, including planetary physics, aerospace engineering, NASA program management, and university level teaching. He has worked at the Aerospace Corporation for almost 20 years. Prior to joining Aerospace Corporation, Dr. Ross was at the Loral Space Systems, spacecraft control system design analysis. Before that he was a planetary physics research assistant at the University of California at Los Angeles.
Dr. Ross earned a Bachelor's degree in Aerospace Engineering from the University of Michigan and a Master's degree in Planetary and Space Physics from the University of California at Los Angeles. Dr. Ross continued on to receive his Space Physics Doctorate from the University of California at Los Angeles and has authored over 25 peer-reviewed publications. He is actively involved with numerous professional societies, including the American Geophysical Union and American Institute of Aeronautics and Astronautics.
Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and drug development, advanced engineering, environmental and energy production. To date, Southern Research has discovered six FDA-approved cancer drugs and discovered four additional drugs that are currently in clinical trials.
Southern Research conducts basic and applied research for both public and private organizations. Clients include the National Institute of Health, the U.S. Departments of Justice, Defense and Energy, Environmental Protection Agency and NASA. Southern Research works with major commercial clients in the pharmaceutical, biotechnology, automotive, energy and manufacturing sectors.
The Aerospace Corporation was created in 1960 because Congress recognized the need for an independent organization, free from conflict of interest, to oversee space and missile programs for the United States Air Force. Aerospace is a nonprofit company that operates a federally funded research and development center for the Air Force and also works with other government agencies and commercial firms. Aerospace dedicated engineers and scientists work independently and objectively to ensure continued access to, and operations in space for the U.S. military and for civil and commercial organizations working in the national interest.
Aerospace participates in every facet of design, development, and operation of national-security space systems, including systems engineering, analysis and development; acquisition support; launch certification; anomaly resolution; new technology application for existing and next-generation space systems; and research and testing at state-of-the-art laboratories staffed by some of the leading scientists in the world. As a trusted agent to the U.S. military for more than 40 years, The Aerospace Corporation has provided broad program support and problem-specific solutions across the full spectrum of national security and space.
Dr. Paul MacCready, Founder and Chairman of the Board, AeroVironment, Inc., 12-8-06
n 1971, Dr. MacCready founded AeroVironment, Inc., a diversified company headquartered in Monrovia, CA. The company provides services, developments, and products in the fields of alternative energy, power electronics, and energy efficient vehicles for operation on land and in air and water. He is Chairman of the Board of AeroVironment, and active in all the newer technology areas.
Dr. MacCready became internationally known in 1977 as the "father of human-powered flight" when his Gossamer Condor made the first sustained, controlled flight by a heavier-than-air craft powered solely by its pilot's muscles. For the feat he received the $95,000 Henry Kremer Prize established in 1959. Two years later, his team created the Gossamer Albatross, another 70-pound craft with a 96 foot wingspan that, with DuPont sponsorship, achieved a human-powered flight across the English Channel. That flight, made by "pilot-engine" Bryan Allen, took almost three hours. It won the new Kremer prize of $213,000, at the time the largest cash prize in aviation history. Some years later, first with DOD and then NASA support, his teams moved Solar Challenger technology into a series of solar-powered stratospheric fliers. The 100' Pathfinder achieved 71,500' in 1997. The 120' Pathfinder Plus climbed over 80,000 feet in 1998. August 2001 the giant 247' Helios reached 96,863' – over 2 miles higher than any plane had ever sustained level flight! Development is ongoing for a system that can provide power for several weeks at 65,000 feet without solar cells. Eventually, such non-polluting fliers will probe conditions in the stratosphere, perform surveillance, and serve as 11 mile high, station-keeping “SkyTower™” radio relays for multichannel, wide bandwidth telecommunications.
Dr. MacCready’s team's first land vehicle was the GM Sunraycer, for which AeroVironment provided project management, systems engineering, aerodynamics and structural design, power electronics development, as well as construction and testing for General Motors and Hughes Aircraft. In November 1987, this solar-powered car won the 1,867 mile race across Australia, averaging 41.6 mph (50 percent faster than the second place vehicle in the field of 24 contestants). The goal of the Sunraycer, in addition to winning the race, was to advance transportation technology that makes fewer demands on the earth's resources and environment, and to inspire students to become engineers. In January 1990, the GM Impact was introduced, a battery-powered sports car with snappy "0 to 60 mph in 8 seconds" performance. GM later turned the Impact into the production vehicle EV 1. In 1985 the AeroVironment team had proposed to GM the initial concept for the Impact. In 1988-89 GM supported AeroVironment to handle program management, systems engineering, design of the electrical and mechanical elements, and build the vehicle, integrating the participation of a dozen GM divisions. This pioneering car became a catalyst for the initial California Zero Emission Vehicle Mandate and the related global developments of battery-powered and alternatively-fueled vehicles.
The unique vehicles produced by MacCready's teams have received international attention through exhibits, books, television documentaries, and innumerable articles and cover stories in magazines and newspapers. They, MacCready, and AeroVironment have become symbols for creativity. The Gossamer Condor, Gossamer Albatross, Solar Challenger, QN, Sunraycer, and Pathfinder Plus were all donated to the Smithsonian. The Gossamer Condor is on permanent display at the Smithsonian's National Air and Space Museum in Washington, D.C. A film about it, "The Flight of the Gossamer Condor", won the Academy Award for Best Documentary - Short Subject in 1978.
Dr. MacCready's achievements have brought him many honors, including the Lifetime Achievement Aviation Week Laureate Award He was included in Time magazine’s “The Century’s Greatest Minds” series “on the 100 most influential people of the century”.
December 06, 2006
Dr. Arthur Caplan, Emmanuel and Robert Hart Professor of Bioethics, Chair, Department of Medical Ethics, and Director, Center for Bioethics, University of Pennsylvania, 12-8-06
Dr. Arthur Leonard Caplan is the Emmanuel and Robert Hart Professor of Bioethics, Chair of the Department of Medical Ethics and Director of the Center for Bioethics at the University of Pennsylvania in Philadelphia.
Prior to coming to Penn in 1994, Dr. Caplan taught at the University of Minnesota, the University of Pittsburgh, and Columbia University. He was the Associate Director of the Hastings Center from 1984-1987.
Born in Boston, Dr. Caplan did his undergraduate work at Brandeis University, and did his graduate work at Columbia University where he received a Ph.D in the history and philosophy of science in 1979. He is the author or editor of 25 books and over 500 papers in refereed journals of medicine, science, philosophy, bioethics and health policy. His most recent book is Smart Mice Not So Smart People (Rowman Littlefield, 2006).
Dr. Caplan has served on a number of national and international committees including Chair of the National Cancer Institute Biobanking Ethics Working Group, Chair of the Advisory Committee to the United Nations on Human Cloning, Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability, a member of the Presidential Advisory Committee on Gulf War Illnesses, the special advisory committee to the International Olympic Committee on genetics and gene therapy, the ethics committee of the American Society of Gene Therapy, and the special advisory panel to the National Institutes of Mental Health on human experimentation on vulnerable subjects.